DNTH
Dianthus Therapeutics, Inc.
90.21
2 x 69.61
2 x 115.58
bid
ask
-
7.27
7.46%
2 @ 08:45 AM
90.31 +0.10 (0.11%)
| Ytd | 118.90% | |
| 1y | 402.28% |
90.08
day range
97.55
17.88
52 week range
98.70
| Open | 96.68 | Prev Close | 97.48 | Low | 90.08 | High | 97.55 | Mkt Cap | 4.93B |
| Vol | 1.61M | Avg Vol | 901.10K | EPS | -4.23 | P/E | N/A | Forward P/E | -19.40 |
| Beta | 0.07 | Short Ratio | 7.33 | Inst. Own | 120.45% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 86.71 | 200-d Avg | 59.86 | 1yr Est | 127.67 |
| Income Statement | |||
| Total Revenue | 463.00K | ||
| Revenues (USD) | 463.00K | ||
| Gross Profit | 463.00K | ||
| Operating Expenses | 47.00M | ||
| Research and Development Expense | 34.53M | ||
| Selling, General and Administrative Expense | 12.47M | ||
| Operating Income | -46.53M | ||
| Net Income | -40.83M | ||
| Net Income Common Stock | -40.83M | ||
| Net Income Common Stock (USD) | -40.83M | ||
| Consolidated Income | -40.83M | ||
| Earnings per Basic Share | -0.85 | ||
| Earnings per Basic Share (USD) | -0.85 | ||
| Earnings per Diluted Share | -0.85 | ||
| Earning Before Interest & Taxes (EBIT) | -40.83M | ||
| Earning Before Interest & Taxes (USD) | -40.83M | ||
| Weighted Average Shares | 48.03M | ||
| Weighted Average Shares Diluted | 48.03M | ||
| Balance Sheet | |||
| Cash and Equivalents | 627.67M | ||
| Cash and Equivalents (USD) | 627.67M | ||
| Investments | 597.46M | ||
| Investments Current | 483.59M | ||
| Investments Non-Current | 113.87M | ||
| Trade and Non-Trade Receivables | 1.23M | ||
| Current Assets | 1.12B | ||
| Property, Plant & Equipment Net | 1.57M | ||
| Total Assets | 1.25B | ||
| Debt Current | 399.00K | ||
| Total Debt | 1.36M | ||
| Current Liabilities | 38.28M | ||
| Debt Non-Current | 965.00K | ||
| Total Liabilities | 45.57M | ||
| Accumulated Retained Earnings (Deficit) | -377.56M | ||
| Accumulated Other Comprehensive Income | -575.00K | ||
| Shareholders Equity | 1.20B | ||
| Shareholders Equity (USD) | 1.20B | ||
| Assets Non-Current | 126.97M | ||
| Total Debt (USD) | 1.36M | ||
| Deferred Revenue | 7.81M | ||
| Liabilities Non-Current | 7.29M | ||
| Trade and Non-Trade Payables | 5.27M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 76.00K | ||
| Net Cash Flow from Financing | 739.41M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 576.58M | ||
| Capital Expenditure | -10.00K | ||
| Issuance (Purchase) of Equity Shares | 740.75M | ||
| Net Cash Flow from Investing | -133.97M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -133.96M | ||
| Net Cash Flow from Operations | -28.86M | ||
| Share Based Compensation | 10.60M | ||